Related references
Note: Only part of the references are listed.Adenocarcinomas of the Esophagogastric Junction Are More Likely to Respond to Preoperative Chemotherapy than Distal Gastric Cancer
Daniel Reim et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
A comprehensive survey of genomic alterations in gastric cancer reveals systematic patterns of molecular exclusivity and co-occurrence among distinct therapeutic targets
Niantao Deng et al.
GUT (2012)
The Aurora Kinase A Inhibitor MLN8237 Enhances Cisplatin-Induced Cell Death in Esophageal Adenocarcinoma Cells
Vikas Sehdev et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Epidermal Growth Factor Receptor (EGFR) Is Overexpressed in High-Grade Dysplasia and Adenocarcinoma of the Esophagus and May Represent a Biomarker of Histological Progression in Barrett's Esophagus (BE)
James Cronin et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
Aurora inhibitor MLN8237 in combination with docetaxel enhances apoptosis and anti-tumor activity in mantle cell lymphoma
Wenqing Qi et al.
BIOCHEMICAL PHARMACOLOGY (2011)
Occurrence of multipolar mitoses and association with Aurora-A/-B kinases and p53 mutations in aneuploid esophageal carcinoma cells
Christiane D. Fichter et al.
BMC CELL BIOLOGY (2011)
Combining Histone Deacetylase Inhibitor Vorinostat with Aurora Kinase Inhibitors Enhances Lymphoma Cell Killing with Repression of c-Myc, hTERT, and microRNA Levels
Leo Kretzner et al.
CANCER RESEARCH (2011)
Aurora kinase A critically contributes to the resistance to anti-cancer drug cisplatin in JAK2 V617F mutant-induced transformed cells
Kazuya Sumi et al.
FEBS LETTERS (2011)
The novel Aurora A kinase inhibitor MLN8237 is active in resistant chronic myeloid leukaemia and significantly increases the efficacy of nilotinib
Kevin R. Kelly et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2011)
Loss of TFF1 is associated with activation of NF-κB-mediated inflammation and gastric neoplasia in mice and humans
Mohammed Soutto et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
THE ROLE OF NEOADJUVANT AND ADJUVANT TREATMENT FOR ADENOCARCINOMA OF THE UPPER GASTROINTESTINAL TRACT
C. Matuschek et al.
EUROPEAN JOURNAL OF MEDICAL RESEARCH (2011)
Anovel Aurora-A kinase inhibitor MLN8237 induces cytotoxicity and cell-cycle arrest in multiple myeloma
Guellue Goerguen et al.
BLOOD (2010)
Aurora kinase A in Barrett's carcinogenesis
Massimo Rugge et al.
HUMAN PATHOLOGY (2010)
Verification and Unmasking of Widely Used Human Esophageal Adenocarcinoma Cell Lines
Jurjen J. Boonstra et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Aurora Kinase Inhibitors - Rising Stars in Cancer Therapeutics?
Altaf A. Dar et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Dopamine and cAMP regulated phosphoprotein MW 32 kDa is overexpressed in early stages of gastric tumorigenesis
Kaushik Mukherjee et al.
SURGERY (2010)
Aurora-A interacts with Cyclin B1 and enhances its stability
Lih Qina et al.
CANCER LETTERS (2009)
The inhibition of Aurora A abrogates the mitotic delay induced by microtubule perturbing agents
Deborah R. Wysong et al.
CELL CYCLE (2009)
P53 Family: At the Crossroads in Cancer Therapy
S. Alsafadi et al.
CURRENT MEDICINAL CHEMISTRY (2009)
The Difference in p53 Mutations between Cancers of the Upper and Lower Gastrointestinal Tract
Eiji Oki et al.
DIGESTION (2009)
Genetic Variations in the PI3K/PTEN/AKT/mTOR Pathway Are Associated With Clinical Outcomes in Esophageal Cancer Patients Treated With Chemoradiotherapy
Michelle A. T. Hildebrandt et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Frequent overexpression of Aurora Kinase A in upper gastrointestinal adenocarcinornas correlates with potent antiapoptotic functions
Altaf A. Dar et al.
CANCER (2008)
Gains and amplifications of c-myc, EGFR, and 20.q13 loci in the no dysplasia-dysplasia-adenocarcinoma sequence of Barrett's esophagus
Agnieszka M. Rygiel et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2008)
Aurora Kinase A Inhibition Leads to p73-Dependent Apoptosis in p53-Deficient Cancer Cells
Altaf A. Dar et al.
CANCER RESEARCH (2008)
Expert opinion on management of gastric and gastro-oesophageal junction adenocarcinoma on behalf of the European Organisation for Research and Treatment of Cancer (EORTC) - gastrointestinal cancer group
Eric Van Cutsem et al.
EUROPEAN JOURNAL OF CANCER (2008)
Telling cells how to die -: Docetaxel therapy in cancer cell lines
Hector Hernandez-Vargas et al.
CELL CYCLE (2007)
Patterns of cancer incidence, mortality, and prevalence across five continents: Defining priorities to reduce cancer disparities in different geographic regions of the world
Farin Kamangar et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Meta-analysis of the p53 mutation database for mutant p53 biological activity reveals a methodologic bias in mutation detection
T Soussi et al.
CLINICAL CANCER RESEARCH (2006)
Decoding the links between mitosis, cancer, and chemotherapy: The mitotic checkpoint, adaptation, and cell death
BAA Weaver et al.
CANCER CELL (2005)
Aurora-A abrogation of p53 DNA binding and transactivation activity by phosphorylation of serine 215
QY Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Dependence of chemotherapy response on p53 mutation status in a panel of human cancer lines maintained in nude mice
M Koike et al.
CANCER SCIENCE (2004)
Aurora-A and an interacting activator, the LIM protein Ajuba, are required for mitotic commitment in human cells
T Hirota et al.
CELL (2003)
AURORA-A amplification overrides the mitotic spindle assembly checkpoint, inducing resistance to Taxol
S Anand et al.
CANCER CELL (2003)
Drosophila aurora-A is required for centrosome maturation and actin-dependent asymmetric protein localization during mitosis
D Berdnik et al.
CURRENT BIOLOGY (2002)
Tumour-amplified kinase BTAK is amplified and overexpressed in gastric cancers with possible involvement in aneuploid formation
C Sakakura et al.
BRITISH JOURNAL OF CANCER (2001)
K-ras codon 12 mutations in Barrett's oesophagus and adenocarcinomas of the oesophagus and oesophagogastric junction
RV Lord et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2000)
Share Paper
